Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 236-291-8 | CAS number: 13282-70-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 2014-10-16 To 2015-01-13
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 015
- Report date:
- 2015
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- fixed dose procedure
- Limit test:
- no
Test material
- Reference substance name:
- N-[3-(dimethylamino)propyl]stearamide monoacetate
- EC Number:
- 236-291-8
- EC Name:
- N-[3-(dimethylamino)propyl]stearamide monoacetate
- Cas Number:
- 13282-70-7
- Molecular formula:
- C23H48N2O.C2H4O2
- IUPAC Name:
- N-[3-(dimethylamino)propyl]stearamide monoacetate
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Crj: CD(SD)
- Remarks:
- CRL The Crl:CD(SD) rat was selected based on consistently acceptable health status and on extensive experience with the strain at DuPont Haskell.
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Rationale for alternative/additional species to rat (if applicable)
- Source: Charles River Laboratories International, Inc., Raleigh, North Carolina, U.S.A.
- Females (if applicable) nulliparous and non-pregnant: [yes]
- Rationale for use of males (if applicable) n/a
- Age at study initiation: 9 weeks old.
- Weight at study initiation: n/a
- Fasting period before study: n/a
- Housing:housed individually in solid-bottom caging with bedding and appropriate species- specific enrichment.
- Historical data:n/a
- Diet (e.g. ad libitum): PMI® Nutrition International, LLC Certified Rodent LabDiet® 5002, ad libitum,
- Water (e.g. ad libitum):tap water, ad libitum.
- Acclimation period:6-day quarantine period.
- Microbiological status when known:Water samples are analyzed for total bacterial counts, and the presence of coliforms, lead, and other contaminants. Samples from freshly washed cages and cage racks are analyzed to ensure adequate sanitation by the cagewashers.
- Method of randomisation in assigning animals to test and control groups:n/a
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-26 °C
- Humidity (%): 30-70%
- Air changes (per hr):
- Photoperiod (hrs dark / hrs light): artificially illuminated (fluorescent light) on an approximate 12-hour light/dark cycle.
IN-LIFE DATES: From: 2014-10-23 To: 2014-11-06
Administration / exposure
- Type of coverage:
- semiocclusive
- Vehicle:
- water
- Remarks:
- deionized water.
- Details on dermal exposure:
- TEST SITE
- Area of exposure: scapular to the lumbar region.37 square centimeters.
- % coverage: 5 cm x 7.4 cm.
- Type of wrap if used: 2-ply gauze patch, then wrapped with stretch gauze bandage and self-adhesive bandage.
REMOVAL OF TEST SUBSTANCE
- Washing (if done): Yes, with paper towels soaked in soap and warm water, and the skin was dried.
- Time after start of exposure: 24 hours
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 5000 mg/Kg bw.
- For solids, paste formed: yes
VEHICLE
The aliquot of test substance designated for an animal was moistened with approximately 4 mL of deionized water for male rats and 3 mL of deionized water for female rats to form a thick paste. - Duration of exposure:
- 24 hours
- Doses:
- - 5000 mg/kg bw; single dose.
- No. of animals per sex per dose:
- 5 males and 5 females.
- Details on study design:
- - Duration of observation period following administration: 14 days.
- Frequency of observations and weighing:daily for clinical signs and toxicity, days 1, 8, and 15 for body weight.
- Necropsy of survivors performed: no
- Clinical signs including body weight: yes.
- Other examinations performed: clinical signs, body weight,organ weights, histopathology, other:examined to detect grossly observable evidence of organ or tissue damage.
Results and discussion
Effect levels
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Mortality:
- There were no instances of mortality at 5000 mg/kg.
- Gross pathology:
- No gross lesions were present in the rats at necropsy.
- Other findings:
- On test days 2 and 3, one female exhibited ulceration on the treated area of skin, which was resolved by test day 4. Clinical signs of hyperkeratosis, desquamation, or epidermal scaling were observed in all animals between test days 3 and 8. The clinical observation of scabbing on the back of one female was present from test day 12-14. At final euthanasia, no clinical abnormalities were present.
At the beginning of the observation period (24 hours after exposure), on test day 2, edema was observed on 5/5 males and 4/5 females, with scores of 1 or 2. All edema was resolved by test day 3. Erythema was observed in all animals between test days 2 and 3, with scores of 1, 2, or 3. From tests 4-9, 1/5 females exhibited erythema scores of 1 or 2.
There were no overall (test day 1-15) body weight losses among any animals.
Any other information on results incl. tables
Individual Erythema Scores Males. Dose: 5000 mg/kg
Days relative to start date | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 12 | 13 | 14 | 15 |
N. animal |
|
|
|
|
|
|
|
|
|
|
|
|
4975 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
4976 | 3 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
4977 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
4978 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
4979 | 3 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Individual Erythema Scores Females. Dose: 5000 mg/kg
Days relative to start date | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 12 | 13 | 14 | 15 |
N. animal |
|
|
|
|
|
|
|
|
|
|
|
|
4980 | 3 | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
4981 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
4982 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
4983 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
4984 | 3 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Individual Edema Scores Males. Dose: 5000 mg/kg
Days relative to start date | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 12 | 13 | 14 | 15 |
N. animal |
|
|
|
|
|
|
|
|
|
|
|
|
4975 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
4976 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
4977 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
4978 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
4979 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Individual Edema Scores Females. Dose: 5000 mg/kg
Days relative to start date | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 12 | 13 | 14 | 15 |
N. animal |
|
|
|
|
|
|
|
|
|
|
|
|
4980 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
4981 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
4982 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
4983 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
4984 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the conditions of this study, the dermal LD50 for H-31339 was greater than 5000 mg/kg of body weight when applied to the skin of male and female rats for 24 hours.
In accordance with the provisions of Directive 67/548/EEC amended by COMMISSION DIRECTIVE 2001/59/EC of 6 August 2001, Annex VI, classification is not required.
According to the United Nations Globally Harmonized System of Classification and Labelling of Chemicals (GHS), Fifth revised edition 2013, classification is not required. - Executive summary:
A single dose of H-31339 was applied to the shaved, intact skin of 5 male and 5 female rats at a dose level of 5000 mg/kg of body weight. The application site was covered with a semi-occlusive dressing for 24 hours, after which the test substance was removed. The rats were observed for 14 days following application. The rats were necropsied to detect grossly observable evidence of organ or tissue damage at the end of the 15-day test period.
There were no instances of mortality.
On test days 2 and 3, one female exhibited ulceration on the treated area of skin, which was resolved by test day 4. Clinical signs of hyperkeratosis, desquamation, or epidermal scaling were observed in all animals between test days 3 and 8. The clinical observation of scabbing on the back of one female was present from test day 12-14. At final euthanasia, no clinical abnormalities were present.
At the beginning of the observation period (24 hours after exposure), on test day 2, edema was observed on 5/5 males and 4/5 females, with scores of 1 or 2. All edema was resolved by test day 3. Erythema was observed in all animals between test days 2 and 3, with scores of 1, 2, or 3. From tests 4-9, 1/5 females exhibited erythema scores of 1 or 2.
There were no overall (test day 1-15) body weight losses among any animals. No gross lesions were present in the rats at necropsy.
Under the conditions of this study, the dermal LD50 for H-31339 was greater than 5000 mg/kg of body weight when applied to the skin of male and female rats for 24 hours.
In accordance with the provisions of Directive 67/548/EEC amended by COMMISSION DIRECTIVE 2001/59/EC of 6 August 2001, Annex VI, classification is not required.
According to the United Nations Globally Harmonized System of Classification and Labelling of Chemicals (GHS), Fifth revised edition 2013, classification is not required.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.